Want to see CAI full AI Analyst Report?
Caris Life Sciences, Inc. (CAI) Income Statement
Caris Life Sciences, Inc. Income Statement
Last quarter (Q2 2026), Caris Life Sciences, Inc.'s total revenue was $263.71M, an increase of 45.38% from the same quarter last year. In Q2, Caris Life Sciences, Inc.'s net income was $-637.00K. See Caris Life Sciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 20 |
|---|---|---|---|---|---|
| $ 812.03M | $ 412.26M | $ 306.13M | $ 258.49M | $ 294.01M | |
| $ 539.17M | $ 178.78M | $ 89.31M | $ 80.02M | $ 184.16M | |
| $ 494.06M | $ 435.90M | $ 408.86M | $ 395.78M | $ 45.07M | |
| Depreciation and Amortization | $ 22.61M | $ 48.91M | $ 49.00M | $ 48.25M | $ 110.65M |
| $ 11.38M | $ -182.95M | $ -260.80M | $ -245.89M | $ 254.46M | |
| $ 45.11M | $ -257.12M | $ -319.55M | $ -315.76M | $ 139.09M | |
| $ -113.20M | $ -24.77M | $ -21.86M | $ -5.07M | $ -109.55M | |
| $ -68.09M | $ -281.89M | $ -341.42M | $ -320.83M | $ 29.53M | |
| $ -537.96M | $ -281.89M | $ -341.42M | $ -320.83M | $ 27.73M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.91 | $ -2.70 | $ -1.82 | $ -1.57 | $ 1.55 |
| Diluted EPS | $ -1.86 | $ -2.70 | $ -1.82 | $ -1.57 | $ 1.55 |
| Weighted Average Shares Outstanding | 282.33M | 254.66M | 254.66M | 254.79M | 17.95M |
| Weighted Average Shares Outstanding (Diluted) | 289.89M | 254.66M | 254.66M | 254.79M | 17.95M |
Currency in USD